stockrow
Friday 6 November 2026
Export ARAY’s income statement to Excel — free account
Accuray Incorporated
ARAY Healthcare Medical Devices
Accuray Incorporated’s revenue for fiscal 2026 (year ended June 2026) was $401.9 million, down 12.3% from fiscal 2025.
- Revenue
- −7.90%
- EPS
- +138.9%
- Free cash flow
- −138.3%
- Total debt
- −25.4%
Quarter to September 2026, against a year earlier
0.11
0.01
−8.33%
Follow ARAY
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 6 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(70.32%) | (101.06%) | (80.08%) | (30.23%) | |
Piotroski F-Score |
3 | 2 | 1 | — | |
| (7.69%) | (9.90%) | (10.77%) | (4.10%) | ||
ROIC |
(8.07%) | (12.63%) | (11.25%) | (21.79%) | |
Return on Tangible Assets |
(29.15%) | (39.64%) | (39.77%) | (14.26%) | |
Average Days of Receivables |
50.92 | 54.99 | 61.21 | 0.00 | |
Free Cash Flow per Share |
(0.02) | (0.21) | (0.10) | (0.20) | |
Free Cash Flow |
(2.66) | (25.84) | (12.84) | (27.05) | |
Capital Expenditures |
(7.21) | (6.72) | (5.86) | (4.08) | |
| Other line items | |||||
Cash ROIC |
(1.21%) | (12.06%) | (5.60%) | (18.27%) | |
Accounts Receivable Turnover |
5.90 | 6.00 | 5.34 | 0.00 | |
Accounts Payable Turnover |
6.48 | 6.33 | 7.79 | 0.00 | |
Inventory Turnover |
2.11 | 2.07 | 2.02 | 0.00 | |
Average Days of Payables |
50.31 | 61.44 | 50.96 | 0.00 | |
Days of Inventory on Hand |
174.51 | 182.25 | 184.80 | 0.00 | |
Tax Rate |
0.07 | 0.06 | 0.04 | 0.13 | |
Research and Development Expense of Revenue |
10.12% | 9.72% | 9.39% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.26% | 20.61% | 20.89% | 0.00% | |
Share Based Compensation of Revenue |
2.05% | 1.77% | 1.61% | 1.28% | |
Interest Coverage |
(0.77) | (0.98) | (0.80) | (1.41) | |
Operating CF/Net income |
(0.13) | 0.41 | 0.14 | 1.32 | |
Depreciation/Fixed assets |
0.39 | 0.48 | 0.59 | 0.74 | |
Capex/Depreciation |
(0.63) | (0.48) | (0.37) | (0.21) | |
Revenue per Share |
3.61 | 3.45 | 3.28 | 2.85 | |
Operating CF per Share |
0.04 | (0.15) | (0.06) | (0.17) | |
Capex per Share |
(0.06) | (0.05) | (0.05) | (0.03) | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 6 Nov 2026